2015•ImmunotherapyOpen access

Cytokine-Induced Killer Cells as Immunotherapy for Solid Tumors: Current Evidence and Perspectives

Lidia Giraudo, Loretta Gammaitoni, Michela Cangemi, Ramona Rotolo, Massimo Aglietta, Dario Sangiolo

Abstract

Cytokine-induced killer (CIK) cells are ex vivo expanded T lymphocytes endowed with potent MHC-independent antitumor activity. CIK cells are emerging as promising therapeutic approach in the field of cancer adoptive immunotherapy, with biologic features favoring their transferability into clinical applications. Aim of this review is to present the biologic characteristic of CIK cells, discussing the main preclinical findings and initial clinical applications in the field of solid tumors.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 29 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Immunotherapy, Cytokine-induced killer cell, Transferability, Immunology, Cytokine, Medicine, Ex vivo, Cancer immunotherapy